Sage Therapeutics Inc (SAGE)
11.78
+0.46
(+4.06%)
USD |
NASDAQ |
May 24, 16:00
11.79
+0.01
(+0.08%)
After-Hours: 20:00
Sage Therapeutics Shareholders Equity (Quarterly): 705.80M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 705.80M |
| December 31, 2023 | 799.53M |
| September 30, 2023 | 816.66M |
| June 30, 2023 | 984.38M |
| March 31, 2023 | 1.133B |
| December 31, 2022 | 1.253B |
| September 30, 2022 | 1.380B |
| June 30, 2022 | 1.504B |
| March 31, 2022 | 1.619B |
| December 31, 2021 | 1.729B |
| September 30, 2021 | 1.836B |
| June 30, 2021 | 1.930B |
| March 31, 2021 | 2.003B |
| December 31, 2020 | 2.072B |
| September 30, 2020 | 657.58M |
| June 30, 2020 | 739.92M |
| March 31, 2020 | 849.21M |
| December 31, 2019 | 944.66M |
| September 30, 2019 | 1.081B |
| June 30, 2019 | 1.203B |
| March 31, 2019 | 1.320B |
| Date | Value |
|---|---|
| December 31, 2018 | 862.97M |
| September 30, 2018 | 988.50M |
| June 30, 2018 | 1.078B |
| March 31, 2018 | 1.059B |
| December 31, 2017 | 475.48M |
| September 30, 2017 | 200.05M |
| June 30, 2017 | 260.30M |
| March 31, 2017 | 318.45M |
| December 31, 2016 | 368.52M |
| September 30, 2016 | 413.74M |
| June 30, 2016 | 257.21M |
| March 31, 2016 | 287.50M |
| December 31, 2015 | 173.70M |
| September 30, 2015 | 198.10M |
| June 30, 2015 | 217.45M |
| March 31, 2015 | 106.51M |
| December 31, 2014 | 121.88M |
| September 30, 2014 | 132.92M |
| June 30, 2014 | -44.79M |
| March 31, 2014 | 53.65M |
| December 31, 2013 | -31.54M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
657.58M
Minimum
Sep 2020
2.072B
Maximum
Dec 2020
1.262B
Average
1.168B
Median
Shareholders Equity (Quarterly) Benchmarks
| Biogen Inc | 15.21B |
| Vanda Pharmaceuticals Inc | 544.00M |
| Ligand Pharmaceuticals Inc | 806.52M |
| ADMA Biologics Inc | 153.71M |
| Axsome Therapeutics Inc | 144.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 767.60M |
| Total Liabilities (Quarterly) | 61.80M |
| Current Ratio | 12.22 |